JAGUAR HEALTH, INC. Research and Development Expense
JAGUAR HEALTH, INC. (JAGX) reported Research and Development Expense of $3.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-19
- JAGUAR HEALTH, INC. research and development expense for the quarter ending 2026-06-30 was $3.34M, a 2.17% increase year-over-year.
- JAGUAR HEALTH, INC. research and development expense for the quarter ending 2026-03-31 was $3.93M, a 5.31% increase year-over-year.
- JAGUAR HEALTH, INC. research and development expense for the quarter ending 2025-12-31 was $14.31M, a 215.68% increase year-over-year.
- JAGUAR HEALTH, INC. research and development expense for the quarter ending 2025-09-30 was $3.66M, a 9.52% decline year-over-year.
- JAGUAR HEALTH, INC. research and development expense for fiscal 2025 was $24.97M, a 50.92% increase from fiscal 2024.
- JAGUAR HEALTH, INC. research and development expense for fiscal 2024 was $16.54M, a 11.05% decline from fiscal 2023.
- JAGUAR HEALTH, INC. research and development expense for fiscal 2023 was $18.60M, a 5.38% increase from fiscal 2022.
- JAGUAR HEALTH, INC. research and development expense for fiscal 2022 was $17.65M, a 17.03% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.34M 10-Q · filed 2026-08-19 | $7.26M 10-Q · filed 2026-08-19 | $21.58M derived: sum of 3 quarters · filed 2026-08-19 | $25.23M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $3.93M 10-Q · filed 2026-05-20 | $18.24M derived: sum of 2 quarters · filed 2026-05-20 | $21.90M derived: sum of 3 quarters · filed 2026-05-20 | $25.16M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | $14.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $17.97M derived: sum of 2 quarters · filed 2026-04-07 | $21.24M derived: sum of 3 quarters · filed 2026-08-19 | $24.97M 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | $3.66M 10-Q · filed 2025-11-14 | $6.92M derived: sum of 2 quarters · filed 2026-08-19 | $10.65M 10-Q · filed 2025-11-14 | $15.19M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $3.27M 10-Q · filed 2026-08-19 | $7.00M 10-Q · filed 2026-08-19 | $11.53M derived: sum of 3 quarters · filed 2026-08-19 | $15.57M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $3.73M 10-Q · filed 2026-05-20 | $8.26M derived: sum of 2 quarters · filed 2026-05-20 | $12.31M derived: sum of 3 quarters · filed 2026-05-20 | $15.96M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $8.58M derived: sum of 2 quarters · filed 2026-04-07 | $12.23M derived: sum of 3 quarters · filed 2026-04-07 | $16.54M 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | $4.04M 10-Q · filed 2025-11-14 | $7.70M derived: sum of 2 quarters · filed 2025-11-14 | $12.01M 10-Q · filed 2025-11-14 | $15.47M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $3.65M 10-Q · filed 2025-08-14 | $7.96M 10-Q · filed 2025-08-14 | $11.43M derived: sum of 3 quarters · filed 2025-08-14 | $17.51M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $4.31M 10-Q · filed 2025-05-15 | $7.78M derived: sum of 2 quarters · filed 2025-05-15 | $13.86M derived: sum of 3 quarters · filed 2025-05-15 | $18.13M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.54M derived: sum of 2 quarters · filed 2025-03-31 | $13.82M derived: sum of 3 quarters · filed 2025-03-31 | $18.60M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $6.08M 10-Q · filed 2024-11-13 | $10.36M derived: sum of 2 quarters · filed 2024-11-13 | $15.13M 10-Q · filed 2024-11-13 | $19.44M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $4.28M 10-Q · filed 2024-08-13 | $9.05M 10-Q · filed 2024-08-13 | $13.36M derived: sum of 3 quarters · filed 2024-08-13 | $19.30M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $4.78M 10-Q · filed 2024-05-14 | $9.09M derived: sum of 2 quarters · filed 2024-05-14 | $15.03M derived: sum of 3 quarters · filed 2024-05-14 | $17.48M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $10.25M derived: sum of 2 quarters · filed 2024-04-01 | $12.70M derived: sum of 3 quarters · filed 2024-04-01 | $17.65M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $5.94M 10-Q · filed 2023-11-14 | $8.39M derived: sum of 2 quarters · filed 2023-11-14 | $13.34M 10-Q · filed 2023-11-14 | $18.82M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $2.45M 10-Q · filed 2023-08-14 | $7.40M 10-Q · filed 2023-08-14 | $12.88M derived: sum of 3 quarters · filed 2023-08-14 | $16.19M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $4.95M 10-Q · filed 2023-05-15 | $10.43M derived: sum of 2 quarters · filed 2023-05-15 | $13.74M derived: sum of 3 quarters · filed 2023-05-15 | $17.61M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $8.79M derived: sum of 2 quarters · filed 2023-03-24 | $12.66M derived: sum of 3 quarters · filed 2023-03-24 | $15.08M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $3.31M 10-Q · filed 2022-11-14 | $7.18M derived: sum of 2 quarters · filed 2022-11-14 | $9.60M 10-Q · filed 2022-11-14 | $11.50M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $3.87M 10-Q · filed 2022-08-22 | $6.29M 10-Q · filed 2022-08-22 | $8.19M derived: sum of 3 quarters · filed 2022-08-22 | $9.71M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | $2.41M 10-Q · filed 2022-05-10 | $4.32M derived: sum of 2 quarters · filed 2022-05-10 | $5.84M derived: sum of 3 quarters · filed 2022-05-10 | $7.25M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.43M derived: sum of 2 quarters · filed 2022-03-11 | $4.83M derived: sum of 3 quarters · filed 2022-03-11 | $6.41M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $1.52M 10-Q · filed 2021-11-17 | $2.93M derived: sum of 2 quarters · filed 2021-11-17 | $4.51M 10-Q · filed 2021-11-17 | $5.90M derived: sum of 4 quarters · filed 2021-11-17 | ||||
| 2020-06-30 | $1.41M 10-Q · filed 2021-08-13 | $2.99M 10-Q · filed 2021-08-13 | $4.38M derived: sum of 3 quarters · filed 2021-08-13 | $5.69M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.58M 10-Q · filed 2021-05-17 | $2.98M derived: sum of 2 quarters · filed 2021-05-17 | $4.28M derived: sum of 3 quarters · filed 2021-05-17 | $5.98M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.70M derived: sum of 2 quarters · filed 2021-03-31 | $4.40M derived: sum of 3 quarters · filed 2021-03-31 | $5.82M 10-K · filed 2021-03-31 | $5.82M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | $1.31M 10-Q · filed 2020-11-16 | $1.31M 10-Q · filed 2019-11-14 | $3.00M derived: sum of 2 quarters · filed 2020-11-16 | $4.43M 10-Q · filed 2020-11-16 | $4.43M 10-Q · filed 2019-11-14 | $5.74M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $1.70M 10-Q · filed 2020-08-13 | $1.70M 10-Q · filed 2019-08-14 | $3.12M 10-Q · filed 2020-08-13 | $3.12M 10-Q · filed 2019-08-14 | $4.43M derived: sum of 3 quarters · filed 2020-08-13 | $5.91M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $1.42M 10-Q · filed 2020-05-15 | $1.42M 10-Q · filed 2019-05-21 | $2.73M derived: sum of 2 quarters · filed 2020-05-15 | $4.21M derived: sum of 3 quarters · filed 2020-05-15 | $5.82M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $2.79M derived: sum of 2 quarters · filed 2020-04-03 | $4.40M derived: sum of 3 quarters · filed 2020-04-03 | $5.15M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $1.48M 10-Q · filed 2019-11-14 | $3.09M derived: sum of 2 quarters · filed 2019-11-14 | $3.84M 10-Q · filed 2019-11-14 | $5.08M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $1.60M 10-Q · filed 2019-08-14 | $2.36M 10-Q · filed 2019-08-14 | $3.60M derived: sum of 3 quarters · filed 2019-08-14 | $4.45M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $757.87K 10-Q · filed 2019-05-21 | $1.99M derived: sum of 2 quarters · filed 2019-05-21 | $2.85M derived: sum of 3 quarters · filed 2019-05-21 | $3.77M derived: sum of 4 quarters · filed 2019-05-21 | ||||
| 2017-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $2.09M derived: sum of 2 quarters · filed 2019-04-10 | $3.01M derived: sum of 3 quarters · filed 2019-04-10 | $4.27M 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | $851.61K 10-Q · filed 2018-11-19 | $1.78M derived: sum of 2 quarters · filed 2018-11-19 | $3.03M 10-Q · filed 2018-11-19 | $4.57M derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | $926.79K 10-Q · filed 2018-08-13 | $2.18M 10-Q · filed 2018-08-13 | $3.72M derived: sum of 3 quarters · filed 2018-08-13 | $5.68M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $1.26M 10-Q · filed 2018-05-15 | $2.79M derived: sum of 2 quarters · filed 2018-05-15 | $4.76M derived: sum of 3 quarters · filed 2018-05-15 | $6.71M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | $3.50M derived: sum of 2 quarters · filed 2018-04-09 | $5.46M derived: sum of 3 quarters · filed 2018-04-09 | $7.21M 10-K · filed 2018-04-09 | ||||
| 2016-09-30 | $1.97M 10-Q · filed 2017-11-20 | $3.92M derived: sum of 2 quarters · filed 2017-11-20 | $5.67M 10-Q · filed 2017-11-20 | $7.73M derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | $1.95M 10-Q · filed 2017-08-09 | $3.71M 10-Q · filed 2017-08-09 | $5.77M derived: sum of 3 quarters · filed 2017-08-09 | $7.01M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $1.75M 10-Q/A · filed 2017-06-23 | $3.81M derived: sum of 2 quarters · filed 2017-06-23 | $5.05M derived: sum of 3 quarters · filed 2017-06-23 | $6.80M derived: sum of 4 quarters · filed 2017-06-23 | ||||
| 2015-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $3.30M derived: sum of 2 quarters · filed 2017-02-15 | $5.05M derived: sum of 3 quarters · filed 2017-02-15 | $6.48M 10-K · filed 2017-02-15 | ||||
| 2015-09-30 | $1.24M 10-Q · filed 2016-11-14 | $2.99M derived: sum of 2 quarters · filed 2016-11-14 | $4.41M 10-Q · filed 2016-11-14 | $5.36M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $1.75M 10-Q · filed 2016-08-15 | $3.17M 10-Q · filed 2016-08-15 | $4.12M derived: sum of 3 quarters · filed 2016-08-15 | $5.25M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $1.42M 10-Q · filed 2016-05-10 | $2.37M derived: sum of 2 quarters · filed 2016-05-10 | $3.49M derived: sum of 3 quarters · filed 2016-05-10 | $4.19M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | $944.35K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $2.07M derived: sum of 2 quarters · filed 2016-03-29 | $2.76M derived: sum of 3 quarters · filed 2016-03-29 | $4.22M 10-K · filed 2016-03-29 | $28.76K 10-Q · filed 2015-06-26 | |||
| 2014-09-30 | $1.13M 10-Q · filed 2015-11-13 | $1.82M derived: sum of 2 quarters · filed 2015-11-13 | $3.28M 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | $691.18K 10-Q · filed 2015-08-13 | $2.15M 10-Q · filed 2015-08-13 | ||||||
| 2014-03-31 | $1.46M 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |